DPYSL2 and HIV infectious disease: Given that CRMP2 is a known substrate of CDK5, along with the recent evidence that CDK5 and CRMP2 are dysregulated in HIVE [8,23,24], activation of CDK5 and subsequent hyperphosphorylation of CRMP2 may be an important mediator of neurodegeneration in HIV infection.